News

EvExia Lifecare Limited submitted a certificate to the BSE Ltd. regarding the dematerialization and rematerialization of its securities for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with confirmation from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, acting as the company`s Registrar and Share Transfer Agent.

Evexia Lifecare Limited informed the BSE Ltd. that the trading window for its equity shares will be closed from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half-year ended September 30, 2026, for all designated persons and their immediate relatives.

Evexia Lifecare Limited informed the BSE that its board of directors approved the conversion of 50 foreign currency convertible bonds into equity shares at a meeting held on September 11, 2026, following approval from shareholders at the Annual General Meeting on July 9, 2022.

EvExia LifeCare Limited informed the BSE that its board approved the company`s report for the year ended March 31, 2026, and fixed the date, time, and place for the 35th Annual General Meeting to be held on Wednesday, September 30, 2026, at 3:00 p.m. IST via video conferencing or other audio visual means, with a book closure from Thursday, September 24, 2026, to Wednesday, September 30, 2026, and appointed M/s. Brajesh Gupta & Co as scrutinizer for the meeting.

Net profit of Evexia Lifecare declined 33.33% to Rs 0.42 crore in the quarter ended June 2026 as against Rs 0.63 crore during the previous quarter ended June 2025. Sales rose 39.84% to Rs 30.89 crore in the quarter ended June 2026 as against Rs 22.09 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales30.8922.09 40 OPM %1.754.89 - PBDT0.681.07 -36 PBT0.570.86 -34 NP0.420.63 -33 Powered by Capital Market - Live News